You are here

drug approvals

FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic

FDA Hit Record Drug and Biologic Approvals in 2020, Despite Ongoing Pandemic

BioSpace

Flag link:

2020 drug approvals rise despite Covid-19

2020 drug approvals rise despite Covid-19

EP Vantage

Flag link:

FDA sped progress for most of 2020's novel drugs

FDA sped progress for most of 2020's novel drugs

RAPS.org

Flag link:

Even before year-end, 2020's new drug approvals match FDA's 2019 stats

Even before year-end, 2020's new drug approvals match FDA's 2019 stats

RAPS.org

Flag link:

Drug rejections rise as Covid-19 bites

Drug rejections rise as Covid-19 bites

EP Vantage

regulatory inspections

Flag link:

Study: Few new drugs have high therapeutic value

Study: Few new drugs have high therapeutic value

RAPS.org

British Medical Journal

therapeutic value

Flag link:

Another strong year for novel drug approvals is in the making

Another strong year for novel drug approvals is in the making

EP Vantage

Flag link:

COVID-19 Vaccine May Pit Science Against Politics

COVID-19 Vaccine May Pit Science Against Politics

NPR

Operation Warp Speed

Flag link:

Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine

Top FDA official says would resign if agency rubber-stamps an unproven COVID-19 vaccine

Reuters

Flag link:

2 major FDA rejections leave some pharma investors worried about intensification of regulations

2 major FDA rejections leave some pharma investors worried about intensification of regulations

Beckers Hospital Review

drug development

Gilead Sciences

Flag link:

Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market

Generic Drugs Approved but not Launched – How to Tell When Generic Drugs Will hit the Market

Drug Patent Watch

Flag link:

Go or no go? Valuable drugs set for FDA decisions

Go or no go? Valuable drugs set for FDA decisions

EP Vantage

belantamab mafodotin

Gilead Sciences

Flag link:

FDA Approvals Roundup: Qwo, Tremfya, Dysport

FDA Approvals Roundup: Qwo, Tremfya, Dysport

RAPS.org

Endo International

Flag link:

Hahn testifies on COVID-19 response, says FDA on target to hit user fee goals

Hahn testifies on COVID-19 response, says FDA on target to hit user fee goals

RAPS.org

Flag link:

Antimicrobial approvals are not bottlenecked by FDA

Antimicrobial approvals are not bottlenecked by FDA

RAPS.org

Flag link:

FDA Says COVID-19 Could Delay Drug Approvals

FDA Says COVID-19 Could Delay Drug Approvals

Motley Fool

Flag link:

Alnylam nabs speedy review, setting up 3rd possible approval in 3 years

Alnylam nabs speedy review, setting up 3rd possible approval in 3 years

Endpoints

Flag link:

From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now

From Gilead To AstraZeneca, Investors Should Watch These Biotech Giants Right Now

Motley Fool

Gilead Sciences

Clovis Oncology

Bristol-Myers Squibb

Flag link:

Study tracks sharp drop in FDA approvals based on 2 pivotal trials

Study tracks sharp drop in FDA approvals based on 2 pivotal trials

RAPS.org

clinical trials

Flag link:

Pages